×
{{login.error}}
{{login.verifyresult}}
×
6~16个字符、区分大小写、必须包含字母和数字
6~16个字符、区分大小写、必须包含字母和数字
密码已经重置成功,快去使用新密码吧!
登录账号
密码已经重置成功,快去使用新密码吧! 登录账号
×

注册成功

确认

PROTAC-linker Conjugate for PAC

PROTAC-linker Conjugate for PAC consist with an antibody conjugated to a PROTAC via a linker. The PROTAC-Antibody Conjugate (PAC) molecules which is antibody conjugated via a linker (L1) to a PROTAC, wherein the PROTAC comprises an ubiquitin E3 ligase binding group, a linker (L2) and a protein binding group. To provide a potent efficacy and a desirable therapeutic index in PAC, the following components are needed. 1. Antibody (Ab): The antibodies in PAC, which are directed against specific antigens on the surface of the cell membrane, will facilitate the efficient targeting of POTAC molecules to the surface of the cell membrane so that they can enter the cell through cytotoxicity. If the antibody in PAC is missing, it is difficult for POTAC molecules to target to the surface of the cell membrane, and they can only enter the cell through cytotoxicity, so the efficiency of PROTAC molecules to enter the cell will be reduced. 2. Linkers (L1): A “linker” (L1) is a bifunctional or multifunctional moiety that can link one or more PROTAC moieties to an antibody (Ab) to form a PAC.

产品编号 产品名称
T18514 PAC PAC is a chemical conjugate consisting of an ADCs linker and PROTACs linked to an antibody. When PAC is conjugated to an antibody, it exhibits enhanced degradation of estrogen receptor-alpha (ERα) in comparison to PROTAC alone.
T18603 PROTAC BRD4 degrader for PAC-1 PROTAC BRD4 degrader for PAC-1 (compound 5) is a chimeric BET degrader GNE-987 conjugated with a disulfide-containing linker[1]. This PROTAC-linker conjugate specifically targets and degrades BRD4, enabling selective proteolysis of PAC-1.
联系我们
400-820-0310
service@tsbiochem.com

上海市静安区江场三路238号8楼